| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.099 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |